Intuitive Surgical EBITDA Margin 2010-2025 | ISRG
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Intuitive Surgical (ISRG) over the last 10 years. The current EBITDA margin for Intuitive Surgical as of March 31, 2025 is .
| Intuitive Surgical EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-03-31 | $8.72B | $2.99B | 34.30% |
| 2024-12-31 | $8.35B | $2.85B | 34.10% |
| 2024-09-30 | $7.87B | $2.56B | 32.57% |
| 2024-06-30 | $7.57B | $2.44B | 32.23% |
| 2024-03-31 | $7.32B | $2.32B | 31.71% |
| 2023-12-31 | $7.12B | $2.22B | 31.19% |
| 2023-09-30 | $6.85B | $2.12B | 30.99% |
| 2023-06-30 | $6.66B | $2.04B | 30.57% |
| 2023-03-31 | $6.43B | $1.96B | 30.48% |
| 2022-12-31 | $6.22B | $1.97B | 31.68% |
| 2022-09-30 | $6.12B | $2.03B | 33.25% |
| 2022-06-30 | $5.96B | $2.07B | 34.67% |
| 2022-03-31 | $5.91B | $2.17B | 36.73% |
| 2021-12-31 | $5.71B | $2.16B | 37.88% |
| 2021-09-30 | $5.49B | $2.12B | 38.54% |
| 2021-06-30 | $5.16B | $1.93B | 37.36% |
| 2021-03-31 | $4.55B | $1.49B | 32.63% |
| 2020-12-31 | $4.36B | $1.34B | 30.81% |
| 2020-09-30 | $4.31B | $1.31B | 30.36% |
| 2020-06-30 | $4.36B | $1.38B | 31.76% |
| 2020-03-31 | $4.61B | $1.65B | 35.74% |
| 2019-12-31 | $4.48B | $1.59B | 35.50% |
| 2019-09-30 | $4.25B | $1.49B | 35.15% |
| 2019-06-30 | $4.04B | $1.42B | 35.21% |
| 2019-03-31 | $3.85B | $1.32B | 34.22% |
| 2018-12-31 | $3.73B | $1.33B | 35.79% |
| 2018-09-30 | $3.57B | $1.32B | 37.09% |
| 2018-06-30 | $3.46B | $1.28B | 37.08% |
| 2018-03-31 | $3.31B | $1.26B | 38.04% |
| 2017-12-31 | $3.14B | $1.17B | 37.37% |
| 2017-09-30 | $3.01B | $1.09B | 36.29% |
| 2017-06-30 | $2.88B | $1.07B | 37.17% |
| 2017-03-31 | $2.79B | $1.07B | 38.22% |
| 2016-12-31 | $2.71B | $1.05B | 38.90% |
| 2016-09-30 | $2.63B | $1.05B | 40.15% |
| 2016-06-30 | $2.53B | $1.00B | 39.42% |
| 2016-03-31 | $2.45B | $0.92B | 37.42% |
| 2015-12-31 | $2.39B | $0.86B | 35.89% |
| 2015-09-30 | $2.31B | $0.82B | 35.37% |
| 2015-06-30 | $2.27B | $0.77B | 33.66% |
| 2015-03-31 | $2.20B | $0.73B | 33.20% |
| 2014-12-31 | $2.13B | $0.65B | 30.63% |
| 2014-09-30 | $2.10B | $0.65B | 30.81% |
| 2014-06-30 | $2.05B | $0.67B | 32.55% |
| 2014-03-31 | $2.12B | $0.75B | 35.58% |
| 2013-12-31 | $2.27B | $0.96B | 42.25% |
| 2013-09-30 | $2.30B | $0.96B | 41.86% |
| 2013-06-30 | $2.34B | $1.00B | 42.70% |
| 2013-03-31 | $2.30B | $1.00B | 43.53% |
| 2012-12-31 | $2.18B | $0.94B | 42.96% |
| 2012-09-30 | $2.07B | $0.92B | 44.27% |
| 2012-06-30 | $1.98B | $0.88B | 44.33% |
| 2012-03-31 | $1.87B | $0.81B | 43.59% |
| 2011-12-31 | $1.76B | $0.76B | 43.46% |
| 2011-09-30 | $1.65B | $0.73B | 44.06% |
| 2011-06-30 | $1.55B | $0.67B | 43.50% |
| 2011-03-31 | $1.47B | $0.64B | 43.41% |
| 2010-12-31 | $1.41B | $0.61B | 43.38% |
| 2010-09-30 | $1.35B | $0.57B | 42.17% |
| 2010-06-30 | $1.28B | $0.54B | 42.01% |
| 2010-03-31 | $1.19B | $0.50B | 41.74% |
| 2009-12-31 | $1.05B | $0.41B | 39.16% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $193.381B | $8.352B |
| Intuitive Surgical Inc designs, manufactures and markets the da Vinci surgical system and related instruments and accessories, which is an advanced robot-assisted surgical system. The surgical system comprises a surgeon's console, patient-side cart, 3-D vision system, da Vinci Skills Simulator and Firefly Fluorescence Imaging. Intuitive Surgical's robot-based da Vinci surgical system enables minimally-invasive surgery that reduces the trauma associated with open surgery. The company also manufactures EndoWrist instruments, such as forceps, scissors, electrocautery tools, scalpels, and other surgical tools, which incorporate wrist joints for natural dexterity for various surgical procedures.?Additionally, the company sells various accessories comprising sterile drapes and vision products and other items that facilitate use of the da Vinci Surgical System, as well as Ion endoluminal system for biopsies. The company operates through three segments: Instruments and Accessories, Systems and Services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $148.604B | 17.98 |
| Edwards Lifesciences (EW) | United States | $43.989B | 28.84 |
| Alcon (ALC) | Switzerland | $42.676B | 28.84 |
| IDEXX Laboratories (IDXX) | United States | $40.337B | 46.36 |
| DexCom (DXCM) | United States | $33.137B | 51.22 |
| STERIS (STE) | Ireland | $23.875B | 26.33 |
| IQVIA Holdings (IQV) | United States | $23.701B | 13.27 |
| Mettler-Toledo (MTD) | United States | $23.155B | 27.54 |
| Waters (WAT) | United States | $20.612B | 29.08 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.146B | 0.00 |
| Hologic (HOLX) | United States | $12.096B | 13.14 |
| Sysmex ADR (SSMXY) | Japan | $10.632B | 30.16 |
| Penumbra (PEN) | United States | $10.399B | 81.62 |
| Masimo (MASI) | United States | $8.140B | 30.03 |
| Globus Medical (GMED) | United States | $7.982B | 19.02 |
| Glaukos (GKOS) | United States | $5.487B | 0.00 |
| Teleflex (TFX) | United States | $5.337B | 8.81 |
| TransMedics (TMDX) | United States | $4.203B | 91.36 |
| Integer Holdings (ITGR) | United States | $4.128B | 21.63 |
| PROCEPT BioRobotics (PRCT) | United States | $3.175B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.284B | 13.60 |
| Veracyte (VCYT) | United States | $2.127B | 29.85 |
| Nihon Kohden (NHNKY) | Japan | $1.943B | 22.28 |
| Elekta AB (EKTAY) | Sweden | $1.922B | 17.28 |
| Alphatec Holdings (ATEC) | United States | $1.820B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.380B | 0.00 |
| Artivion (AORT) | United States | $1.222B | 114.44 |
| Pulse Biosciences (PLSE) | United States | $1.136B | 0.00 |
| OPKO Health (OPK) | United States | $0.999B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.956B | 5.08 |
| SiBone (SIBN) | United States | $0.783B | 0.00 |
| IRadimed (IRMD) | United States | $0.650B | 32.96 |
| RxSight (RXST) | United States | $0.637B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.626B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.597B | 13.05 |
| NeuroPace (NPCE) | United States | $0.580B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.569B | 8.86 |
| Delcath Systems (DCTH) | United States | $0.561B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.506B | 0.00 |
| AxoGen (AXGN) | United States | $0.504B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.494B | 13.15 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.435B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.384B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.370B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.333B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.277B | 0.00 |
| Neuronetics (STIM) | United States | $0.263B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.219B | 13.27 |
| Alpha Tau Medical (DRTS) | Israel | $0.211B | 0.00 |
| Inogen (INGN) | United States | $0.176B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.175B | 0.00 |
| CVRx (CVRX) | United States | $0.174B | 0.00 |
| 908 Devices (MASS) | United States | $0.172B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.172B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.165B | 0.00 |
| Accuray (ARAY) | United States | $0.162B | 0.00 |
| LENSAR (LNSR) | United States | $0.160B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.144B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.143B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.131B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.107B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.097B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.093B | 0.00 |
| InspireMD (NSPR) | Israel | $0.078B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.077B | 46.90 |
| EDAP TMS S.A (EDAP) | France | $0.066B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.059B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.055B | 16.67 |
| Hyperfine (HYPR) | United States | $0.042B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.040B | 0.00 |
| Spectral AI (MDAI) | United States | $0.037B | 0.00 |
| Envoy Medical (COCH) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.032B | 0.00 | |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.018B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.58 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |